Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis
Importance Positron emission tomography (PET) combined with fludeoxyglucose F 18 (FDG)
is recommended for the noninvasive diagnosis of pulmonary nodules suspicious for lung …
is recommended for the noninvasive diagnosis of pulmonary nodules suspicious for lung …
ACR appropriateness criteria® lung cancer screening
EF Donnelly, EA Kazerooni, E Lee, TS Henry… - Journal of the American …, 2018 - Elsevier
Lung cancer remains the leading cause of cancer death in both men and women. Smoking
is the single greatest risk factor for the development of lung cancer. For patients between the …
is the single greatest risk factor for the development of lung cancer. For patients between the …
Classification model to estimate MIB-1 (Ki 67) proliferation index in NSCLC patients evaluated with 18F-FDG-PET/CT
B Palumbo, R Capozzi, F Bianconi… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: Proliferation biomarkers such as MIB-1 are strong predictors of clinical
outcome and response to therapy in patients with non-small-cell lung cancer, but they …
outcome and response to therapy in patients with non-small-cell lung cancer, but they …
Asian Perspective on Lung Cancer Screening
T Mimae, M Okada - Thoracic Surgery Clinics, 2023 - thoracic.theclinics.com
Lung cancer is the leading cause of cancer-related mortality in Japan and worldwide. 1, 2 In
2021, an estimated 127,400 new cases (85,300 in men and 42,100 in women) of lung and …
2021, an estimated 127,400 new cases (85,300 in men and 42,100 in women) of lung and …
[HTML][HTML] Experimental study of peripheral-blood pro-surfactant protein B for screening non-small cell lung cancer
Y He, Z Jiang, F Tong, M Li, X Yin, S Hu… - Acta Cirurgica …, 2017 - SciELO Brasil
Purpose: To evaluate the possibility of using peripheral-blood presurfactant protein B (Pro-
SFTPB) for screening non-small cell lung cancer (NSCLC). Methods: A total of 873 healthy …
SFTPB) for screening non-small cell lung cancer (NSCLC). Methods: A total of 873 healthy …
Analysis on early detection of lung cancer by PET/CT scan
HQ Wang, L Zhao, J Zhao, Q Wang - Asian Pacific Journal of …, 2015 - koreascience.kr
Background: This systemic analysis was conducted to to evaluate the application value of
positron emission tomography/computed tomography (PET/CT) in early diagnosis of lung …
positron emission tomography/computed tomography (PET/CT) in early diagnosis of lung …
[HTML][HTML] The probability of nodal metastasis in novel T-factor: the applicability of sublobar resection
Background Recently sublobar resection is often indicated for small-sized peripheral lung
cancer according to size or the consolidation/tumor ratio on CT; however, the T-factor …
cancer according to size or the consolidation/tumor ratio on CT; however, the T-factor …
[HTML][HTML] A study of the pathological outcome of positron emission tomography-computed tomography 2-(18F)-fluro-2-deoxy-D-glucose avid lesion: A 5 years …
Aims and Objectives: To study the sensitivity, specificity, positive and negative predictive
value (PPV and NPV) of PET-CT in the detection of malignant lesions for all sites using …
value (PPV and NPV) of PET-CT in the detection of malignant lesions for all sites using …
Role of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in the Evaluation of Suspicious Pulmonary Nodules
BW Carter, JP Lichtenberger III, GS Shroff… - Seminars in …, 2017 - Elsevier
The prevalence of noncalcified pulmonary nodules in smokers or former smokers is between
23% and 69% based on findings from the Early Lung Cancer Action Project and a lung …
23% and 69% based on findings from the Early Lung Cancer Action Project and a lung …
The prognostic value of PET/CT in clinical stage I lung cancer patients: A propensity-match analysis.
BY Wang, WH Hung, JY Huang, HC Chen, CH Lin… - 2019 - researchsquare.com
Introduction The application of PET/CT directly improved treatment choice and management
in 25% of non-small cell lung cancer patients and 29% of small cell lung cancer patients …
in 25% of non-small cell lung cancer patients and 29% of small cell lung cancer patients …